Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Health Technology Assessment (Winchester, England)|March 6, 2015
Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disordersLesley Uttley, Alison Scope, Matt Stevenson, et al.Journal of Medical Economics|February 16, 2021
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic modelNanxin Li, Eileen K Sawyer, Konrad Maruszczyk, et al.Health Technology Assessment (Winchester, England)|December 6, 2017
The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysisAllan Wailoo, Emma S Hock, Matt Stevenson, et al.Health Technology Assessment (Winchester, England)|October 20, 2021
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysisKyla H Thomas, Michael N Dalili, José A López-López, et al.Health Technology Assessment (Winchester, England)|June 30, 2016
Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluationMatt Stevenson, Abdullah Pandor, Marrissa Martyn-St James, et al.Health Technology Assessment (Winchester, England)|May 4, 2016
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluationMatt Stevenson, Rachel Archer, Jon Tosh, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse EventsEdna Keeney, Nicky J Welton, Matt Stevenson, et al.Addiction (Abingdon, England)|October 12, 2021
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trialsKyla H Thomas, Michael N Dalili, José A López-López, et al.Health Technology Assessment (Winchester, England)|January 6, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-frameworkPeter Murphy, David Glynn, Sofia Dias, et al.Health Technology Assessment (Winchester, England)|November 2, 2016
A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fracturesSarah Davis, Marrissa Martyn-St James, Jean Sanderson, et al.Pageof 7